Indo US Bio-Tech passes all five AGM resolutions including auditor appointment

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Indo US Bio-Tech Limited passed all five resolutions at its 22nd AGM held on September 30, 2026.
  • Resolutions included adoption of FY26 financials, auditor appointment, and borrowing limit approval.
  • Total votes polled were 1,48,41,548, with 98.52% in favour across all items.
  • Promoter group held 1,36,93,643 shares, while public non-institutions voted 11,47,905 shares.
  • No institutional shareholder votes were recorded during the remote e-voting process.
powered bylight_fuzz_icon
52479992

*this image is generated using AI for illustrative purposes only.

Indo US Bio-Tech Limited concluded its 22nd Annual General Meeting on September 30, 2026, with all five proposed resolutions passing by requisite majority. The meeting was conducted via video conferencing.

The company reported that 17 shareholders attended the virtual meeting. This included six members from the promoter and promoter group and eleven public shareholders. Voting results were scrutinized by Amrish Gandhi & Associates, Company Secretaries.

Resolution Outcomes

The shareholders approved the adoption of audited financial statements for FY26, the re-appointment of a director retiring by rotation, and the appointment of new statutory auditors. Additionally, a special resolution regarding borrowing limits and an ordinary resolution approving related party transactions were passed.

Resolution Type Votes in Favour (%) Votes Against (%) Status
Adoption of Audited Financials Ordinary 98.52 1.48 Passed
Re-appointment of Director Ordinary 98.52 1.48 Passed
Appointment of Statutory Auditor Ordinary 98.52 1.48 Passed
Borrowing Limit Approval Special 98.52 1.48 Passed
Related Party Transaction Ordinary 98.52 1.48 Passed

Voting Participation Details

Remote e-voting was conducted between September 27 and September 29, 2026. The total number of votes polled across all resolutions stood at 1,48,41,548. Promoters and promoter group members cast 1,36,93,643 votes, representing 100% of their holding. Public non-institutional shareholders polled 11,47,905 votes, which constituted 18.05% of their total holdings.

Notably, no votes were recorded from public institutional shareholders. For the resolution concerning the re-appointment of Mrs. Priyanka Samarth Patel, promoter votes were declared invalid due to interest in the matter, yet the resolution still passed with a substantial majority of valid votes.

Historical Stock Returns for Indo Us Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-1.88%-1.73%-5.14%-21.85%-42.15%-73.77%

How will the newly approved borrowing limits impact Indo US Bio-Tech's capital expenditure plans and debt-to-equity ratio in the upcoming fiscal year?

What specific strategic initiatives or expansion projects are driving the need for increased borrowing capacity and related party transactions?

Given the low public institutional participation, what steps is the company taking to enhance governance transparency to attract long-term institutional investors?

Indo US Bio-Tech sets Sept 30 AGM; seeks ₹250 cr borrowing limit

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Indo US Bio-Tech holds 22nd AGM on Sept 30, 2026, via VC/OAVM
  • Bhagat & Associates proposed as statutory auditors for five years
  • Board seeks approval for borrowing up to ₹250 crore above capital/reserves
  • Reappointment of director Priyanka Samarth Patel on agenda
  • Related-party transaction limit set at ₹10 crore per type
powered bylight_fuzz_icon
50149385

*this image is generated using AI for illustrative purposes only.

Indo US Bio-Tech Limited has scheduled its 22nd Annual General Meeting (AGM) for September 30, 2026. The meeting will address the appointment of statutory auditors, the reappointment of a retiring director, and significant special business items including enhanced borrowing limits and related-party transaction approvals.

The Board of Directors approved the draft notice and Directors' Report in its meeting held on September 5, 2026. The AGM will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) at 2:30 pm.

Auditor Appointment and Director Reappointment

The Board recommended appointing M/s. Bhagat & Associates, Chartered Accountants (FRN: 101100W), as Statutory Auditors for a period of five consecutive years. This term runs from the conclusion of the 22nd AGM until the conclusion of the 27th AGM, subject to shareholder approval.

Additionally, shareholders will vote on the reappointment of Mrs. Priyanka Samarth Patel (DIN: 07941023) as a Director. She retires by rotation at this meeting and is eligible for reappointment.

Special Business: Borrowing and Related Parties

The AGM agenda includes two special resolutions:

  1. Borrowing Limits: Shareholders will decide on empowering the Board to borrow up to ₹250 crore over and above the aggregate of paid-up capital, free reserves, and securities premium. The resolution also permits creating charges on company assets up to ₹100 crore.
  2. Related Party Transactions: Approval is sought for transactions with related parties under Section 188 of the Companies Act, 2013, with an annual limit of ₹10 crore for each type of transaction.

Disclosures for FY26 show various related-party dealings, including advances given to Indo US Agriseeds Limited (₹3.45 crore) and Patel Beej Nigam (₹1.20 crore). Loans taken from promoter Jagdish D. Ajudia amounted to ₹11 lakh, while repayments totaled ₹11.60 lakh.

AGM Logistics and Voting

Shareholders holding shares on the record date of September 23, 2026, are eligible to vote. The remote e-voting period runs from September 27, 2026, at 9:00 am to September 29, 2026, at 5:00 pm. M/s. Amrish Gandhi & Associates will scrutinize the e-voting process.

Event Date/Time
Record Date September 23, 2026
E-Voting Start September 27, 2026, 9:00 am
E-Voting End September 29, 2026, 5:00 pm
AGM Date September 30, 2026, 2:30 pm

The book closure for equity shares is from September 23, 2026, to September 30, 2026, inclusive, in compliance with Regulation 42 of the SEBI (LODR) Regulations 2015.

Historical Stock Returns for Indo Us Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-1.88%-1.73%-5.14%-21.85%-42.15%-73.77%

How will the approved ₹250 crore borrowing limit impact Indo US Bio-Tech's debt-to-equity ratio and future credit ratings?

What specific strategic initiatives or capital expenditures is the company planning to fund with the newly authorized debt capacity?

Could the ₹10 crore annual limit for related-party transactions signal increased operational reliance on promoter entities like Indo US Agriseeds?

More News on Indo Us Bio-Tech

1 Year Returns:-42.15%